Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Addiction Biology
|
July 12, 2016
Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D<sub>2</sub> /D<sub>3</sub> dopamine system
Philippe Pfeifer, Oliver Tüscher, Hans Georg Buchholz, et al.
Biological Psychiatry
|
August 2, 2011
Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [(18)F]fallypride positron emission tomography study
Katja N Spreckelmeyer, Michael Paulzen, Mardjan Raptis, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
December 29, 2022
Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis
Nazar Kuzo, Ekkehard Haen, Dominic M Ho, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
May 18, 2024
The impact of pregnancy on the pharmacokinetics of antiseizure medications: A systematic review and meta-analysis of data from 674 pregnancies
Georgios Schoretsanitis, Kristina M Deligiannidis, Nicholas Kasperk, et al.
Psychopharmacology
|
October 4, 2022
Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis
Xenia M Hart, Christoph Hiemke, Luzie Eichentopf, et al.
British Journal of Clinical Pharmacology
|
April 5, 2022
The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia
Arnim Johannes Gaebler, Michelle Finner-Prével, Sarah Lammertz, et al.
Translational Psychiatry
|
February 16, 2023
Functional connectivity signatures of NMDAR dysfunction in schizophrenia-integrating findings from imaging genetics and pharmaco-fMRI
Arnim J Gaebler, Nilüfer Fakour, Felix Stöhr, et al.
The Journal of Clinical Psychiatry
|
May 21, 2020
Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie
Georgios Schoretsanitis, John M Kane, Christoph U Correll, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
June 24, 2024
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics
Xenia Marlene Hart, Gerhard Gründer, Nicolas Ansermot, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
March 2, 2018
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>
Georgios Schoretsanitis, Michael Paulzen, Stefan Unterecker, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Addiction Biology
|
July 12, 2016
Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D<sub>2</sub> /D<sub>3</sub> dopamine system
Philippe Pfeifer, Oliver Tüscher, Hans Georg Buchholz, et al.
Biological Psychiatry
|
August 2, 2011
Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [(18)F]fallypride positron emission tomography study
Katja N Spreckelmeyer, Michael Paulzen, Mardjan Raptis, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
December 29, 2022
Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis
Nazar Kuzo, Ekkehard Haen, Dominic M Ho, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
May 18, 2024
The impact of pregnancy on the pharmacokinetics of antiseizure medications: A systematic review and meta-analysis of data from 674 pregnancies
Georgios Schoretsanitis, Kristina M Deligiannidis, Nicholas Kasperk, et al.
Psychopharmacology
|
October 4, 2022
Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis
Xenia M Hart, Christoph Hiemke, Luzie Eichentopf, et al.
British Journal of Clinical Pharmacology
|
April 5, 2022
The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia
Arnim Johannes Gaebler, Michelle Finner-Prével, Sarah Lammertz, et al.
Translational Psychiatry
|
February 16, 2023
Functional connectivity signatures of NMDAR dysfunction in schizophrenia-integrating findings from imaging genetics and pharmaco-fMRI
Arnim J Gaebler, Nilüfer Fakour, Felix Stöhr, et al.
The Journal of Clinical Psychiatry
|
May 21, 2020
Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie
Georgios Schoretsanitis, John M Kane, Christoph U Correll, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
June 24, 2024
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics
Xenia Marlene Hart, Gerhard Gründer, Nicolas Ansermot, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
March 2, 2018
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>
Georgios Schoretsanitis, Michael Paulzen, Stefan Unterecker, et al.
Page
of 10